← SynDRA
TESTOSTERONE ENANTHATE
SynDRA canonical compound SYN0022921 — structure-anchored drug synonym record
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | AR |
|---|
| Mechanism of action | Androgen receptor agonist |
|---|
All known targets
- AR
- SIGMAR1
- NR3C1
- CYP19A1
- SERPINA6
- SHBG
- CYP51A1
- Ar
- PGR
- ERG2
- Srd5a1
- Srd5a2
Mechanisms of action (all sources)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Androgen Receptor Agonists
- Androgens
- Hormones
- Androgen
ATC classes
- G03B · ANDROGENS
- ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION
Cross-references
Synonyms
- DELATESTRYL
- DITATE-DS
- TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE
- XYOSTED (AUTOINJECTOR)
- Xyosted
- testosterone enantate
- testosterone heptylate
- testosterone oenanthate
- Testosterone enantate
- Androtardyl
- Testosteroni enantas
- NSC-17591
- Delatestryl
- Primoteston depot
- Testosterone enanthate component of ditate-ds
- Xyosted (autoinjector)
- Testosterone enanthate ciii
- testosterone-enanthate
- testosterone enanthate (usp-rs)
- DITATE-DS COMPONENT TESTOSTERONE ENANTHATE
- 7Z6522T8N9
- testosterone enanthate ciii (usp-rs)
- testosterone enantate (ep monograph)
- Testosterone heptanoate
- testosterone enanthate (usp monograph)
- Testinon
- Everone
- Testosterone heptylate
- Testosterone 17-enanthate
- Testate
- 3-oxoandrost-4-en-17beta-yl heptanoate
- CHEBI:9464
- NSC17591
- Primosteston
- Testo-Enant
- Andro LA
Reported adverse events
- BP
- Nausea
- Hirsutism
- Hypersensitivity
- Oligospermia
- Inflammation
- Myocardial infarction
- Cardiovascular disorder
- Headache
- Hypertension
- Depression
- Weight increased
Look up TESTOSTERONE ENANTHATE in the interactive SynDRA portal →